LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 76 of 166
Next
>>
>
1876 to 1900 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Mean Relative Cell Count	Standard Error of the Mean for Relative Cell Count	Mean Normalized Growth Rate Inhibition Value	Standard Error of the Mean for Normalized Growth Rate Inhibition Value
MDA-MB-231	Afatinib	1.11	uM	LJP6	0.6861	0.0339	0.6410	0.0520
MDA-MB-231	Afatinib	3.33	uM	LJP6	0.6028	0.0167	0.5368	0.0247
MDA-MB-231	Afatinib	10	uM	LJP6	0.1707	0.0184	-0.2053	0.0658
MDA-MB-231	GSK1904529A	0.04	uM	LJP6	0.8272	0.0515	0.8131	0.0536
MDA-MB-231	GSK1904529A	0.12	uM	LJP6	0.8724	0.0266	0.8637	0.0259
MDA-MB-231	GSK1904529A	0.37	uM	LJP6	0.8985	0.0169	0.8926	0.0155
MDA-MB-231	GSK1904529A	1.11	uM	LJP6	0.9066	0.0031	0.9004	0.0061
MDA-MB-231	GSK1904529A	3.33	uM	LJP6	0.9717	0.0114	0.9705	0.0118
MDA-MB-231	GSK1904529A	10	uM	LJP6	0.9424	0.0123	0.9394	0.0136
MDA-MB-231	Linsitinib	0.04	uM	LJP5	0.8074	0.0249	0.7913	0.0274
MDA-MB-231	Linsitinib	0.12	uM	LJP5	0.8543	0.0350	0.8434	0.0386
MDA-MB-231	Linsitinib	0.37	uM	LJP5	0.8707	0.0444	0.8607	0.0492
MDA-MB-231	Linsitinib	1.11	uM	LJP5	0.8723	0.0343	0.8619	0.0391
MDA-MB-231	Linsitinib	3.33	uM	LJP5	0.8498	0.0421	0.8376	0.0467
MDA-MB-231	Linsitinib	10	uM	LJP5	0.7283	0.0487	0.6973	0.0572
MDA-MB-231	Ruxolitinib	0.04	uM	LJP5	0.9424	0.0353	0.9385	0.0377
MDA-MB-231	Ruxolitinib	0.12	uM	LJP5	0.9285	0.0274	0.9224	0.0300
MDA-MB-231	Ruxolitinib	0.37	uM	LJP5	0.9387	0.0467	0.9327	0.0503
MDA-MB-231	Ruxolitinib	1.11	uM	LJP5	0.9537	0.0365	0.9496	0.0395
MDA-MB-231	Ruxolitinib	3.33	uM	LJP5	0.9532	0.0225	0.9501	0.0249
MDA-MB-231	Ruxolitinib	10	uM	LJP5	0.7189	0.1175	0.6729	0.1523
MDA-MB-231	Momelotinib	0.04	uM	LJP5	0.8690	0.0312	0.8588	0.0339
MDA-MB-231	Momelotinib	0.12	uM	LJP5	0.7972	0.0253	0.7772	0.0305
MDA-MB-231	Momelotinib	0.37	uM	LJP5	0.7124	0.0384	0.6776	0.0504
MDA-MB-231	Momelotinib	1.11	uM	LJP5	0.5979	0.0734	0.5274	0.1047

|<
<<
Previous
Page 76 of 166
Next
>>
>
1876 to 1900 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)